Tokyo Tape
Sign in
← Nippon Kayaku

Quarterly report · Q1

4272.TEDINET S100OWP3
Period2022-04-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥48.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥184.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥46.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥6.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥5.9bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥8.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥23.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥8.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥7.6bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.3bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥5.3bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥325.4bnat 2022-06-30Cons.Assets
Total assets¥315.5bnat 2022-03-31Cons.Assets
Total assets¥297.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥72.8bnat 2022-06-30Cons.Liabilities
Total liabilities¥69.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥252.5bnat 2022-06-30Cons.Net assets
Net assets / equity¥246.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥230.8bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥46.5bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥38.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥35.412022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.882021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥35.42022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥101.652021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥30.872021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio77.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.2%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥27m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥473m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥69m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥69m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥1.9bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue2022-04-01 → 2022-06-30¥21.2bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue external2022-04-01 → 2022-06-30¥21.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥12.6bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥12.6bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E00836-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥2.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue external2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥46.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥46.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥42m
—segment totalsegment profit2022-04-01 → 2022-06-30¥7.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥48.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥48.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥69m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥8.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥25m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥444m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥66m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥66m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥1.7bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue2021-04-01 → 2021-06-30¥20.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue external2021-04-01 → 2021-06-30¥20.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥40m
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentsegment profit2021-04-01 → 2021-06-30¥3.4bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E00836-000Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue2021-04-01 → 2021-06-30¥11.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue external2021-04-01 → 2021-06-30¥11.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.8bn
—segment totalrevenue2021-04-01 → 2021-06-30¥44.3bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥44.2bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥40m
—segment totalsegment profit2021-04-01 → 2021-06-30¥7.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥46.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥46.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥66m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥7.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 393
ItemContextValueUnit
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember66000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-66000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00836-000FunctionalChemicalsReportableSegmentsMember20130000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00836-000MedicineReportableSegmentsMember12773000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00836-000SafetySystemsReportableSegmentsMember11382000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember44286000000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember2227000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember46513000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-66000000JPY
Net salesPrior1YTDDuration46447000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00836-000FunctionalChemicalsReportableSegmentsMember3399000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00836-000MedicineReportableSegmentsMember1925000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00836-000SafetySystemsReportableSegmentsMember1799000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember7124000000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember444000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember7569000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-1681000000JPY
Operating incomePrior1YTDDuration5887000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00836-000FunctionalChemicalsReportableSegmentsMember21117000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00836-000MedicineReportableSegmentsMember12632000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00836-000SafetySystemsReportableSegmentsMember12385000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember46135000000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember2161000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember48296000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration48296000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00836-000FunctionalChemicalsReportableSegmentsMember42000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00836-000MedicineReportableSegmentsMember0JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00836-000SafetySystemsReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember42000000JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember27000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember69000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-69000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00836-000FunctionalChemicalsReportableSegmentsMember21159000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00836-000MedicineReportableSegmentsMember12632000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00836-000SafetySystemsReportableSegmentsMember12385000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember46177000000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember2188000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember48366000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-69000000JPY
Net salesCurrentYTDDuration48296000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00836-000FunctionalChemicalsReportableSegmentsMember3760000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00836-000MedicineReportableSegmentsMember2374000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00836-000SafetySystemsReportableSegmentsMember1662000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember7797000000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember473000000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember8270000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-1889000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass